Q4 2022 13F Holders as of 12/31/2022
-
Type / Class
-
Equity / Common Stock, $0.001 par value
-
Shares outstanding
-
117M
-
Number of holders
-
224
-
Total 13F shares, excl. options
-
117M
-
Shares change
-
+2.75M
-
Total reported value, excl. options
-
$1.25B
-
Value change
-
+$29.7M
-
Put/Call ratio
-
0.84
-
Number of buys
-
101
-
Number of sells
-
-89
-
Price
-
$10.64
Significant Holders of DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) as of Q4 2022
258 filings reported holding DVAX - DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value as of Q4 2022.
DYNAVAX TECHNOLOGIES CORP - Common Stock, $0.001 par value (DVAX) has 224 institutional shareholders that have filed 13F forms with the Securities Exchange Commission (SEC).
These institutions hold a total of 117M shares
.
Largest 10 shareholders include BlackRock Inc. (19.1M shares), FEDERATED HERMES, INC. (12.6M shares), STATE STREET CORP (9.99M shares), VANGUARD GROUP INC (8.34M shares), Chicago Capital, LLC (5.86M shares), Fisher Asset Management, LLC (4.08M shares), Bain Capital Life Sciences Investors, LLC (3.92M shares), PFM Health Sciences, LP (3.81M shares), BLAIR WILLIAM & CO/IL (2.49M shares), and Deep Track Capital, LP (2.33M shares).
This table shows the top 224 institutional shareholders of the company equity. This data is sourced directly from the SEC via 13F filings.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price $ |
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.